XERS insider trading — Xeris Biopharma Holdings, Inc.
No open-market insider purchases or sales were filed for Xeris Biopharma Holdings, Inc. (XERS) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent XERS insider transactions
Every Form 4 filed by Xeris Biopharma Holdings, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Hecht Beth | See Remarks | S · Sale · 10b5-1 | Direct | 16,666 | $9.41 | $157K | Form 4 |
| Oct 1, 2026 | Mcculloch Kevin | See Remarks | S · Sale · 10b5-1 | Direct | 15,000 | $9.41 | $141K | Form 4 |
| Oct 1, 2026 | Pieper Steven | See Remarks | S · Sale · 10b5-1 | Direct | 5,000 | $9.41 | $47K | Form 4 |
| Sep 28, 2026 | Mcculloch Kevin | See Remarks | S · Sale · 10b5-1 | Direct | 25,000 | $10.00 | $250K | Form 4 |
| Sep 1, 2026 | Hecht Beth | See Remarks | S · Sale · 10b5-1 | Direct | 16,666 | $8.49 | $141K | Form 4 |
| Sep 1, 2026 | Mcculloch Kevin | See Remarks | S · Sale · 10b5-1 | Direct | 15,000 | $8.49 | $127K | Form 4 |
| Sep 1, 2026 | Pieper Steven | See Remarks | S · Sale · 10b5-1 | Direct | 5,000 | $8.50 | $42K | Form 4 |
| Aug 1, 2026 | Shannon John Patrick Jr | See Remarks | F · Tax withholding | Direct | 36,645 | $8.08 | $296K | Form 4 |
| Aug 1, 2026 | Mcculloch Kevin | See Remarks | F · Tax withholding | Direct | 21,918 | $8.08 | $177K | Form 4 |
| Aug 12, 2026 | Pieper Steven | See Remarks | S · Sale · 10b5-1 | Direct | 5,000 | $8.50 | $42K | Form 4 |
| Aug 3, 2026 | Mcculloch Kevin | See Remarks | S · Sale · 10b5-1 | Direct | 15,000 | $8.02 | $120K | Form 4 |
| Aug 3, 2026 | Hecht Beth | See Remarks | S · Sale · 10b5-1 | Direct | 16,666 | $8.01 | $134K | Form 4 |
XERS insider trading FAQ
Are insiders buying XERS stock?
Not on the open market. In the last 90 days, Xeris Biopharma Holdings, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading XERS?
No insider bought or sold on the open market in the last 90 days.
Where does XERS insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.